Nanoscalic silver possesses broad-spectrum antimicrobial activities and exhibits fewer toxicological side effects than silver sulfadiazine (Q57305774)
Jump to navigation
Jump to search
scholarly article by Oliver Brandt et al published May 2012 in Nanomedicine: Nanotechnology, Biology and Medicine
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nanoscalic silver possesses broad-spectrum antimicrobial activities and exhibits fewer toxicological side effects than silver sulfadiazine |
scholarly article by Oliver Brandt et al published May 2012 in Nanomedicine: Nanotechnology, Biology and Medicine |
Statements
Nanoscalic silver possesses broad-spectrum antimicrobial activities and exhibits fewer toxicological side effects than silver sulfadiazine (English)
0 references
May 2012
0 references
8
0 references
4
0 references
478-88
0 references
478-488
0 references